Sign in
4

Changes in Ownership

MoonLake Immunotherapeutics Filed Acc 0001213900-24-086271

Director sold 171,000 shares at $53.72 ($9,186,120)

From the SEC's structured data for this filing

Trades in this filing

Sturge Simon · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2024-10-04 Sale : show line 1 in the form −171,000 $53.72 $9,186,120 171,980 D
Open-market sales · 171,000 sh · avg $53.72 · $9,186,120
Loading xslF345X05/ownership.xml…